BRPI0819241A2 - Compostos derivados de amina para o tratamento de distúrbios e doenças oftálmicas - Google Patents

Compostos derivados de amina para o tratamento de distúrbios e doenças oftálmicas

Info

Publication number: BRPI0819241A2
Authority: BR; Brazil
Prior art keywords: diseases; amine; treatment; derived compounds; ophthalmic disorders
Prior art date: 2007-11-01

Application number

BRPI0819241-3A

Other languages

English (en)

Inventor

Ian Leslie Scott

Vladimir A Kuksa

Mark W Orme

Feng Hong

Thomas L Little

Jr.

Ryo Kubota

Original Assignee

Acucela Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-11-01

Filing date

2008-10-22

Publication date

2015-05-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40097866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0819241(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-10-22 Application filed by Acucela Inc filed Critical Acucela Inc

2015-05-05 Publication of BRPI0819241A2 publication Critical patent/BRPI0819241A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/20—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated the carbon skeleton being saturated and containing rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
- C07C217/10—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/16—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring not being further substituted
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/52—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/64—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
- C07C217/66—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
- C07C217/72—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/76—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and etherified hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/20—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C219/22—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
- C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
- C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C07C225/18—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings the carbon skeleton containing also rings other than six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/54—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/38—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/08—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by singly-bound oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/30—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/29—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/30—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/32—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D309/06—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyridine Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Pyrane Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

BRPI0819241-3A 2007-11-01 2008-10-22 Compostos derivados de amina para o tratamento de distúrbios e doenças oftálmicas BRPI0819241A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US98466707P	2007-11-01	2007-11-01
PCT/US2008/012060 WO2009058216A1 (en)	2007-11-01	2008-10-22	Amine derivative compounds for treating ophthalmic diseases and disorders

Publications (1)

Publication Number	Publication Date
BRPI0819241A2 true BRPI0819241A2 (pt)	2015-05-05

Family

ID=40097866

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0819241-3A BRPI0819241A2 (pt)	2007-11-01	2008-10-22	Compostos derivados de amina para o tratamento de distúrbios e doenças oftálmicas

Country Status (21)

Country	Link
US (5)	US8076516B2 (pt)
EP (1)	EP2111223A4 (pt)
JP (3)	JP5592265B2 (pt)
KR (2)	KR101270122B1 (pt)
CN (1)	CN101917980B (pt)
AR (1)	AR070950A1 (pt)
AU (1)	AU2008319397B2 (pt)
BR (1)	BRPI0819241A2 (pt)
CA (1)	CA2704199C (pt)
CL (1)	CL2008003120A1 (pt)
CO (1)	CO6501155A2 (pt)
EC (1)	ECSP10010226A (pt)
GB (1)	GB2455176A (pt)
IL (1)	IL205112A0 (pt)
MX (1)	MX2010004718A (pt)
MY (2)	MY167602A (pt)
PH (2)	PH12015501208A1 (pt)
RU (1)	RU2536040C2 (pt)
SG (1)	SG185939A1 (pt)
TW (1)	TWI446904B (pt)
WO (1)	WO2009058216A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8299307B2 (en) *	2007-06-29	2012-10-30	Acucela Inc.	Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
US8076516B2 (en)	2007-11-01	2011-12-13	Acucela, Inc.	Amine derivative compounds for treating ophthalmic diseases and disorders
NZ592057A (en) *	2008-09-05	2013-01-25	Acucela Inc	Sulfur-linked compounds for treating opthalmic diseases and disorders
IN2012DN00352A (pt)	2009-06-16	2015-08-21	Bikam Pharmaceuticals Inc
JP5786713B2 (ja) *	2009-09-09	2015-09-30	三菱瓦斯化学株式会社	環状化合物、その製造方法、感放射線性組成物およびレジストパターン形成方法
WO2012021629A2 (en)	2010-08-11	2012-02-16	Philadelphia Health & Education Corporation	Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease
US8835472B2 (en) *	2010-09-02	2014-09-16	Boehringer Ingelheim International Gmbh	Compounds, pharmaceutical compositions and uses thereof
EA026121B1 (ru) *	2011-06-14	2017-03-31	Бикам Фармасьютикалз, Инк.	Опсин-связывающие лиганды, композиции и способы их использования
EP2768307B1 (en)	2011-10-19	2020-03-18	Bikam Pharmaceuticals, Inc.	Opsin-binding ligands, compositions and methods of use
US9353063B2 (en)	2011-11-30	2016-05-31	Bikam Pharmaceuticals, Inc.	Opsin-binding ligands, compositions and methods of use
AU2012346537A1 (en) *	2011-12-01	2014-07-17	Bikam Pharmaceuticals, Inc.	Opsin-binding ligands, compositions and methods of use
GB201201138D0 (en) *	2012-01-20	2012-03-07	Ist Superiore Sanita	Neurological therapies
HK1210969A1 (en)	2012-01-20	2016-05-13	奥克塞拉有限公司	Substituted heterocyclic compounds for disease treatment
TW201406707A (zh)	2012-05-04	2014-02-16	Acucela Inc	用以治療糖尿病性視網膜病變及其他眼部疾病之方法
EP2740356A1 (de)	2012-12-05	2014-06-11	Bayer CropScience AG	Substituierte (2Z)-5(1-Hydroxycyclohexyl)pent-2-en-4-insäure-Derivate
CN105072903A (zh)	2012-12-05	2015-11-18	拜耳作物科学股份公司	取代的1-(芳基乙炔基)-环己醇、1-(杂芳基乙炔基)-环己醇、1-(杂环基乙炔基)-环己醇和1-(环烯基乙炔基)-环己醇用作抵抗非生物植物胁迫的活性剂的用途
EP2740720A1 (de)	2012-12-05	2014-06-11	Bayer CropScience AG	Substituierte bicyclische- und tricyclische Pent-2-en-4-insäure -Derivate und ihre Verwendung zur Steigerung der Stresstoleranz in Pflanzen
WO2014100695A1 (en)	2012-12-21	2014-06-26	Epizyme, Inc.	Prmt5 inhibitors and uses thereof
US9221794B2 (en)	2012-12-21	2015-12-29	Epizyme, Inc.	PRMT5 inhibitors and uses thereof
JP2016505001A (ja)	2012-12-21	2016-02-18	エピザイム，インコーポレイティド	Ｐｒｍｔ５阻害剤およびその使用
SI2935222T1 (sl)	2012-12-21	2019-02-28	Epizyme Inc.	Inhibitorji PRMT5 in njihove uporabe
WO2014100730A1 (en)	2012-12-21	2014-06-26	Epizyme, Inc.	Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
WO2014164905A1 (en) *	2013-03-12	2014-10-09	Acucela Inc.	Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders
US20160151410A1 (en) *	2013-07-02	2016-06-02	The Trustees Of Columbia University In The City Of New York	Clearance of bioactive lipids from membrane structures by cyclodextrins
JP6537500B2 (ja)	2013-09-20	2019-07-03	ビオマリンプハルマセウトイカルインコーポレイテッド	疾患治療用のグルコシルセラミドシンターゼ阻害剤
ES2769780T3 (es)	2013-10-28	2020-06-29	Univ Drexel	Tratamientos novedosos para los trastornos de atención y cognitivos y para la demencia asociada a un trastorno neurodegenerativo
AU2015301196A1 (en)	2014-08-04	2017-01-12	Epizyme, Inc.	PRMT5 inhibitors and uses thereof
WO2018157129A1 (en)	2017-02-27	2018-08-30	Case Western Reserve University	Visual cycle modulators
CN115073273B (zh) *	2021-03-15	2024-09-17	中国医学科学院药物研究所	二苯烷类化合物及其制备方法、药物组合物和用途
US20250034094A1 (en) *	2021-11-22	2025-01-30	Purdue Research Foundation	A fast and efficient process for the preparation of n-retinylidene-n-retinylethanolamine (a2e)
KR20230091052A (ko) *	2021-12-14	2023-06-22	(주)프레이저테라퓨틱스	폴리유비퀴틴화에 의한 표적 단백질 또는 폴리펩티드의 분해용 신규 화합물

Family Cites Families (106)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2750416A (en) *	1950-12-21	1956-06-12	Rohm & Haas	Aminomethylphenols and method for their preparation
CH396941A (de)	1959-08-10	1965-08-15	Ciba Geigy	Verfahren zur Herstellung neuer sekundärer Amine
GB884663A (en)	1958-11-06	1961-12-13	Ciba Ltd	New amines and processes for their manufacture
US3911151A (en)	1973-10-10	1975-10-07	Us Agriculture	Method for coloring fruits and vegetables
US4013633A (en) *	1975-06-27	1977-03-22	Eastman Kodak Company	Yellow azopyrazoline dye releasing redox compounds for photographic color transfer
JPS5313597A (en)	1976-07-22	1978-02-07	Grumman Aerospace Corp	Supply water control system for fire extinguishing hose
DE2710997C3 (de)	1977-03-14	1980-08-14	Dr. Karl Thomae Gmbh, 7950 Biberach	4-Alkoxy carbonylamino-phenyläthanolamine, deren Herstellung und deren Verwendung als Arzneimittel
US4118584A (en) *	1977-04-11	1978-10-03	The Upjohn Company	9-Deoxy-9-methylene-16-phenyl-PGF compounds
IE46886B1 (en) *	1977-05-17	1983-10-19	Allen & Hanburys Ltd	Aminoalkyl-benzene derivatives
DD150456A5 (de) *	1979-03-01	1981-09-02	Ciba Geigy Ag	Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
DE3171475D1 (en)	1980-05-31	1985-08-29	Ciba Geigy Ag	Aryl-phenyl-acetylene compounds
JPS60130561A (ja) *	1983-12-16	1985-07-12	Torii Yakuhin Kk	アミジン誘導体およびそれを含む強心剤
JO1410B1 (en) *	1984-11-03	1986-11-30	سميث كلاين اند فرينش لابوراتوريز ليمتد	Compounds
GB8503425D0 (en) *	1985-02-11	1985-03-13	Ici Plc	Alkanolamine derivatives
JPS625969A (ja) *	1985-07-03	1987-01-12	Hokuriku Seiyaku Co Ltd	キナゾリン誘導体
ES2011255B3 (es)	1985-12-24	1990-01-01	Merck & Co Inc	Bloqueadores beta selectivos para los ojos.
IT1197348B (it) *	1986-09-30	1988-11-30	Boehringer Biochemia Srl	Cinnamilammine, processo per la loro preparazione e composizioni farmaceutiche che le contengono
US5217999A (en)	1987-12-24	1993-06-08	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Styryl compounds which inhibit EGF receptor protein tyrosine kinase
JPH0228112A (ja)	1988-04-21	1990-01-30	Kaken Pharmaceut Co Ltd	点眼用眼圧調整剤
US5227372A (en)	1990-03-07	1993-07-13	Children's Medical Center Corporation	Method for retaining ophthalmological agents in ocular tissues
DE4041780A1 (de) *	1990-12-24	1992-06-25	Boehringer Mannheim Gmbh	Neue amine, verfahren zu ihrer herstellung, sowie diese verbindungen enthaltende arzneimittel
EP0525360B1 (en)	1991-07-30	1998-03-25	Korea Research Institute Of Chemical Technology	Novel phenylacetamide derivatives and processes for the preparation thereof
JPH05222073A (ja) *	1992-02-13	1993-08-31	Sumitomo Pharmaceut Co Ltd	骨選択性エストロゲン
JP2579602B2 (ja) *	1992-10-21	1997-02-05	吉富製薬株式会社	２−アミノ−１，３−プロパンジオール化合物および免疫抑制剤
US6071970A (en)	1993-02-08	2000-06-06	Nps Pharmaceuticals, Inc.	Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
GB2276161A (en) *	1993-03-17	1994-09-21	Glaxo Group Ltd	Aniline and benzanilide derivatives
GB2276163A (en) *	1993-03-17	1994-09-21	Glaxo Group Ltd	Pyridine compounds.
GB2276164A (en) *	1993-03-17	1994-09-21	Glaxo Group Ltd	Aniline and benzanilide derivatives
GB2276165A (en) *	1993-03-17	1994-09-21	Glaxo Group Ltd	Aniline and benzanilide compounds.
US5523302A (en) *	1993-11-24	1996-06-04	The Du Pont Merck Pharmaceutical Company	Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists
WO1995017888A1 (en) *	1993-12-30	1995-07-06	Smithkline Beecham Corporation	Phenylmethyl hexanamides, and the use thereof
CN1143950A (zh)	1994-01-19	1997-02-26	比克荷兰有限公司	含硝酰基的苄胺衍生物及其在治疗心血管疾病和治疗升高眼压中的应用
JPH07247274A (ja) *	1994-03-10	1995-09-26	Wakamoto Pharmaceut Co Ltd	ピバル酸テトラゾリルフェニルエステル誘導体、それらを有効成分として含有するエラスターゼ阻害剤及び肺障害治療剤
WO1996006068A1 (en)	1994-08-22	1996-02-29	Yoshitomi Pharmaceutical Industries, Ltd.	Benzene compound and medicinal use thereof
US5698560A (en) *	1995-03-01	1997-12-16	Kyowa Hakko Kogyo Co., Ltd.	Imidazoquinazoline derivatives
US5631280A (en) *	1995-03-29	1997-05-20	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
GB9519077D0 (en)	1995-09-18	1995-11-15	Fujisawa Pharmaceutical Co	New heterocyclic compounds
AU1794697A (en) *	1996-03-06	1997-09-22	Novartis Ag	7-alkyl-pyrrolo{2,3-d}pyrimidines
DE19609827A1 (de) *	1996-03-13	1997-09-18	Hoechst Ag	Aminoalkyl- und Acylaminoalkylether, Verfahren zu deren Herstellung und ihre Verwendung als Bradykinin-Rezeptorantagonisten
JP3663732B2 (ja) *	1996-04-19	2005-06-22	コニカミノルタホールディングス株式会社	ハロゲン化銀カラー写真感光材料
EP1361210B1 (en)	1996-08-12	2008-12-24	Celgene Corporation	Novel immunotherapeutic agents and their use in the reduction of cytokine levels
DE19643592A1 (de)	1996-10-22	1998-04-23	Bayer Ag	Verfahren zur Herstellung von alpha-Alkoxy-alpha-trifluormethyl-arylessigsäureestern und -arylessigsäuren
TW542822B (en) *	1997-01-17	2003-07-21	Ajinomoto Kk	Benzamidine derivatives
KR100510794B1 (ko) *	1997-02-04	2005-08-31	더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소	살진균 카르복스아미드
AU6422098A (en) *	1997-03-24	1998-10-20	Kyowa Hakko Kogyo Co. Ltd.	Benzene derivatives
TW593331B (en)	1997-07-25	2004-06-21	Inspire Pharmaceuticals Inc	Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
US6051605A (en)	1997-08-08	2000-04-18	Warner-Lambert Company	Method of treating psychosis and schizophrenia
US6171837B1 (en)	1997-09-29	2001-01-09	The Trustees Of Columbia University In The City Of New York	Mouse and human 9-cis-retinol dehydrogenase
GB9725883D0 (en) *	1997-12-05	1998-02-04	Ciba Geigy Ag	Organic compounds
EP0957073A1 (en) *	1998-05-12	1999-11-17	Schwarz Pharma Ag	Novel derivatives of 3,3-diphenylpropylamines
US6331537B1 (en)	1998-06-03	2001-12-18	Gpi Nil Holdings, Inc.	Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
ES2252978T3 (es)	1998-09-18	2006-05-16	Alcon Manufacturing Ltd.	Agonistas 5ht2 serotonergicos para tratar el glaucoma.
FR2783518B1 (fr) *	1998-09-21	2001-08-03	Bioprojet Soc Civ	Inhibiteurs de lta4 hydrolase
US6372463B1 (en)	1999-05-06	2002-04-16	The President & Fellows Of Harvard College	Mutations in nucleic acid molecules encoding 11-CIS retinol dehydrogenase, the mutated proteins, and uses thereof
SE9904044D0 (sv) *	1999-11-09	1999-11-09	Astra Ab	Compounds
JP2003518122A (ja)	1999-12-21	2003-06-03	ジーピーアイエヌアイエルホールディングズインコーポレーテッド	ヒダントイン誘導体化合物、医薬合成品およびこれらの使用方法
WO2001058487A1 (en) *	2000-02-09	2001-08-16	Mitsubishi Pharma Corporation	Therapeutic and/or preventive agents for optic nerve diseases and retinal diseases
FR2805815B1 (fr) *	2000-03-01	2002-05-17	Sanofi Synthelabo	Derives de polyfluoroalkylimidazole, leur preparation et leur application en therapeutique
AU2001248365A1 (en) *	2000-03-23	2001-10-03	Mitsubishi Pharma Corporation	2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives
US20030032078A1 (en)	2001-01-23	2003-02-13	Board Of Regents, The University Of Texas System	Methods and compositions for the treatment of macular and retinal degenerations
JP2002322054A (ja) *	2001-04-26	2002-11-08	Dai Ichi Seiyaku Co Ltd	薬剤排出ポンプ阻害薬
PA8557501A1 (es)	2001-11-12	2003-06-30	Pfizer Prod Inc	Benzamida, heteroarilamida y amidas inversas
KR20030042401A (ko)	2001-11-22	2003-05-28	주식회사 어드밴스파워	휴대용 전자기기 자동 밧데리 충전장치 휴대용 전자기기수동 밧데리 충전장치
WO2003059872A1 (en)	2001-12-31	2003-07-24	Bayer Pharmaceuticals Corporation	Avb3 and avb5 integrin antagonists and methods of treating diseases or conditions associated with avb3 and avb5 integrins
JP4164031B2 (ja) *	2002-02-14	2008-10-08	ファルマシアコーポレーション	Ｐ３８ｍａｐキナーゼのモジュレータとしての置換されたピリジノン
DK1551793T3 (en)	2002-06-19	2016-04-25	Gnt Pharma Co Ltd	Tetrafluorobenzyl derivatives and pharmaceutical compositions containing these for the prevention and treatment of acute and chronic neurodegenerative diseases of the central nervous system
WO2004007472A1 (ja) *	2002-07-10	2004-01-22	Ono Pharmaceutical Co., Ltd.	Ｃｃｒ４アンタゴニストおよびその医薬用途
DE10235312A1 (de)	2002-08-01	2004-02-12	Basf Ag	Verfahren zur Herstellung von Aminoalkoxybenzylaminen und Aminoalkoxybenzonitrilen als Zwischenprodukte
WO2004014903A1 (en) *	2002-08-02	2004-02-19	Ab Science	2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
US7612238B2 (en)	2002-09-13	2009-11-03	Novartis Ag	Amino-propanol derivatives
AU2003258662A1 (en) *	2002-10-02	2004-04-23	Merck Patent Gmbh	Use of 4-amino-quinazolines as anti cancer agents
EP2324823A3 (en)	2003-03-14	2011-11-16	University of Washington	Retinoid replacements and opsin agonists and methods for the use thereof
CA2523226A1 (en) *	2003-04-25	2004-11-11	Pharmacia & Upjohn Company Llc	Halogen substituted 3,3-diphenylpropylamines (tolterodine) having antimuscarinic activity
DE602004022153D1 (de)	2003-05-14	2009-09-03	High Point Pharmaceuticals Llc	Verbindungen zur behandlung von obesitas
US8008525B2 (en) *	2003-11-26	2011-08-30	Takeda Pharmaceutical Company Limited	Receptor function regulating agent
JP2007525496A (ja) *	2004-02-17	2007-09-06	プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ	黄班変性症を含む眼科疾患の管理
US7566808B2 (en) *	2004-02-17	2009-07-28	President And Fellows Of Harvard College	Management of ophthalmologic disorders, including macular degeneration
KR101216372B1 (ko) *	2004-03-30	2013-01-04	버텍스 파마슈티칼스 인코포레이티드	Ｊａｋ 및 기타 단백질 키나제의 억제제로서 유용한 아자인돌
MXPA06012333A (es) *	2004-04-30	2007-01-17	Takeda Pharmaceutical	Compuesto de amida heterociclico y uso del mismo como un inhibidor mmp-13.
WO2006037117A1 (en) *	2004-09-27	2006-04-06	Amgen Inc.	Substituted heterocyclic compounds and methods of use
US8114887B2 (en) *	2004-10-13	2012-02-14	Merck, Sharp & Dohme Corp.	Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
DE102004057595A1 (de) *	2004-11-29	2006-06-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
AU2005314039B2 (en) *	2004-12-08	2008-01-31	Revision Therapeutics, Inc.	Methods, assays and compositions for treating retinol-related diseases
JP2006176443A (ja) *	2004-12-22	2006-07-06	Shionogi & Co Ltd	メラニン凝集ホルモン受容体アンタゴニスト
AU2006206249A1 (en)	2005-01-21	2006-07-27	Nicox S.A.	Cardiovascular compounds comprising heterocyclic nitric oxide donor group compositions and methods of use
US20060252107A1 (en) *	2005-02-22	2006-11-09	Acucela, Inc.	Compositions and methods for diagnosing and treating retinal diseases
WO2006120544A1 (en) *	2005-05-06	2006-11-16	Pfizer Limited	β-AMINO ACID DERIVATIVES
TW200744567A (en) *	2005-09-23	2007-12-16	Alcon Inc	Phenylethylamine analogs and their use for treating glaucoma
CN101287707A (zh) *	2005-10-13	2008-10-15	德福根有限公司	激酶抑制剂
JP5201817B2 (ja) *	2005-10-28	2013-06-05	大塚製薬株式会社	医薬組成物
WO2007076448A2 (en)	2005-12-23	2007-07-05	Alcon, Inc.	Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye
JP2009523134A (ja)	2006-01-13	2009-06-18	マクギルユニバーシティー	抗うつ作用ならびに睡眠誘発性を有する新規なメラトニンリガンド
WO2008005794A2 (en)	2006-06-30	2008-01-10	Symbol Technologies, Inc.	Techniques for peer wireless switch discovery within a mobility domain
KR100817538B1 (ko) *	2006-07-05	2008-03-27	한국화학연구원	신규 치환된―１ｈ―퀴나졸린―２,４―디온 유도체, 이의제조방법 및 이를 함유하는 약학적 조성물
EP2035406A4 (en) *	2006-07-05	2009-08-05	Korea Res Inst Chem Tech	NEW SUBSTITUTED 1H-CHINAZOLIN-2,4-DION DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
BRPI0713187A2 (pt) *	2006-07-20	2012-10-16	Mehmet Kahraman	método de inibir rho-quinase, método de tratamento de doença mediada por rho-quinase, composto e composição farmacêutica
PE20080906A1 (es)	2006-08-17	2008-07-05	Kemia Inc	Derivados heteroarilo como inhibidores de citocina
TW200821276A (en) *	2006-08-18	2008-05-16	Leo Pharma As	Substituted acetylenic compounds useful for the treatment of diseases
MX2009003981A (es) *	2006-10-26	2009-04-27	Amgen Inc	Agentes moduladores del receptor de calcio.
CA2669687C (en) *	2006-11-15	2013-09-10	Forest Laboratories Holdings Limited	Phthalazine derivatives
EP2102171A1 (en) *	2006-12-11	2009-09-23	Boehringer Ingelheim International GmbH	New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
US8071779B2 (en) *	2006-12-18	2011-12-06	Inspire Pharmaceuticals, Inc.	Cytoskeletal active rho kinase inhibitor compounds, composition and use
US20090170841A1 (en) *	2007-04-20	2009-07-02	Acucela Inc.	Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders
US8299307B2 (en) *	2007-06-29	2012-10-30	Acucela Inc.	Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
CN102172330B (zh)	2007-07-10	2013-03-27	株式会社东芝	X射线摄影装置以及图像处理显示装置
US8076516B2 (en)	2007-11-01	2011-12-13	Acucela, Inc.	Amine derivative compounds for treating ophthalmic diseases and disorders

2008
- 2008-10-22 US US12/256,415 patent/US8076516B2/en not_active Expired - Fee Related
- 2008-10-22 CN CN2008801237801A patent/CN101917980B/zh not_active Expired - Fee Related
- 2008-10-22 TW TW097140564A patent/TWI446904B/zh not_active IP Right Cessation
- 2008-10-22 AR ARP080104610A patent/AR070950A1/es not_active Application Discontinuation
- 2008-10-22 BR BRPI0819241-3A patent/BRPI0819241A2/pt not_active IP Right Cessation
- 2008-10-22 JP JP2010532020A patent/JP5592265B2/ja not_active Expired - Fee Related
- 2008-10-22 AU AU2008319397A patent/AU2008319397B2/en not_active Ceased
- 2008-10-22 RU RU2010122261/04A patent/RU2536040C2/ru not_active IP Right Cessation
- 2008-10-22 WO PCT/US2008/012060 patent/WO2009058216A1/en not_active Ceased
- 2008-10-22 GB GB0819399A patent/GB2455176A/en not_active Withdrawn
- 2008-10-22 MY MYPI2014003070A patent/MY167602A/en unknown
- 2008-10-22 MX MX2010004718A patent/MX2010004718A/es active IP Right Grant
- 2008-10-22 SG SG2012080727A patent/SG185939A1/en unknown
- 2008-10-22 MY MYPI2010001934A patent/MY156662A/en unknown
- 2008-10-22 KR KR1020107012034A patent/KR101270122B1/ko not_active Expired - Fee Related
- 2008-10-22 CL CL2008003120A patent/CL2008003120A1/es unknown
- 2008-10-22 EP EP08832783A patent/EP2111223A4/en not_active Withdrawn
- 2008-10-22 CA CA2704199A patent/CA2704199C/en not_active Expired - Fee Related
- 2008-10-22 KR KR1020127034304A patent/KR20130012969A/ko not_active Ceased
2010
- 2010-04-15 IL IL205112A patent/IL205112A0/en unknown
- 2010-05-05 CO CO10053441A patent/CO6501155A2/es not_active Application Discontinuation
- 2010-06-01 EC EC2010010226A patent/ECSP10010226A/es unknown
2011
- 2011-10-21 US US13/278,909 patent/US8450527B2/en not_active Expired - Fee Related
- 2011-10-21 US US13/278,925 patent/US8716529B2/en not_active Expired - Fee Related
2013
- 2013-06-07 JP JP2013120506A patent/JP5676687B2/ja not_active Expired - Fee Related
2014
- 2014-03-26 US US14/226,665 patent/US9056849B2/en not_active Expired - Fee Related
- 2014-12-25 JP JP2014261934A patent/JP2015091842A/ja active Pending
2015
- 2015-05-22 US US14/720,705 patent/US9452153B2/en not_active Expired - Fee Related
- 2015-05-29 PH PH12015501208A patent/PH12015501208A1/en unknown
- 2015-05-29 PH PH12015501207A patent/PH12015501207A1/en unknown

Also Published As

Publication number	Publication date
CL2008003120A1 (es)	2009-10-09
CA2704199A1 (en)	2009-05-07
US20090281149A1 (en)	2009-11-12
WO2009058216A1 (en)	2009-05-07
GB2455176A (en)	2009-06-03
US20120041038A1 (en)	2012-02-16
US9452153B2 (en)	2016-09-27
ECSP10010226A (es)	2010-07-30
RU2010122261A (ru)	2011-12-10
TWI446904B (zh)	2014-08-01
US8716529B2 (en)	2014-05-06
EP2111223A4 (en)	2012-08-15
MX2010004718A (es)	2010-07-28
IL205112A0 (en)	2010-11-30
JP2013216665A (ja)	2013-10-24
KR20100100844A (ko)	2010-09-15
CA2704199C (en)	2016-01-19
US20120041039A1 (en)	2012-02-16
TW200924736A (en)	2009-06-16
JP2015091842A (ja)	2015-05-14
AU2008319397B2 (en)	2013-01-31
PH12015501208A1 (en)	2016-06-06
KR101270122B1 (ko)	2013-05-31
CN101917980B (zh)	2013-12-11
PH12015501207A1 (en)	2016-06-06
SG185939A1 (en)	2012-12-28
JP5592265B2 (ja)	2014-09-17
AR070950A1 (es)	2010-05-19
CO6501155A2 (es)	2012-08-15
US8450527B2 (en)	2013-05-28
KR20130012969A (ko)	2013-02-05
US20140323530A1 (en)	2014-10-30
US9056849B2 (en)	2015-06-16
GB0819399D0 (en)	2008-11-26
RU2536040C2 (ru)	2014-12-20
EP2111223A1 (en)	2009-10-28
CN101917980A (zh)	2010-12-15
HK1151736A1 (en)	2012-02-10
MY167602A (en)	2018-09-20
JP2011502983A (ja)	2011-01-27
AU2008319397A1 (en)	2009-05-07
MY156662A (en)	2016-03-15
JP5676687B2 (ja)	2015-02-25
US8076516B2 (en)	2011-12-13
US20160193181A1 (en)	2016-07-07

Publication	Publication Date	Title
BRPI0819241A2 (pt)	2015-05-05	Compostos derivados de amina para o tratamento de distúrbios e doenças oftálmicas
BRPI0919920A2 (pt)	2016-02-16	compostos para tratamento de doenças e desordens oftálmicas
BRPI0716844A2 (pt)	2013-10-22	Inidores de quinase úteis para o tratamento de doenças proliferativas
BRPI0810082A2 (pt)	2014-10-21	3-imidazolil-indóis para o tratamento de doenças proliferativas
BRPI0716435A2 (pt)	2014-03-04	Compostos para o tratamento de doenças proliferativas
BRPI0812755A2 (pt)	2014-09-30	Compostos de derivados de fenil alquinila para tratar doenças, e desordens oftálmicas
BRPI0918527A2 (pt)	2015-12-01	compostos para o tratamento de disturbios do cns
BRPI0812361A2 (pt)	2015-02-03	Derivados de pirazol heteroaril-substituídos úteis parao tratamento de distúrbios e doenças hiperproliferativos associados à angiogênese
BRPI0908026A2 (pt)	2015-07-21	Métodos para o tratamento de doenças do intestino
BRPI0816712A2 (pt)	2016-11-08	terapia de intervalo para o tratamento de tinnitus
BRPI0807717A2 (pt)	2014-05-20	Inibidores de quinase úteis para o tratamento de doenças mieloproliferativas e outras doenças proliferativas.
BRPI0916862A2 (pt)	2016-02-10	compostos úteis para o tratamento de doenças degenerativas e inflamatórias
BRPI0815038A2 (pt)	2015-03-17	Uso de derivados de benzamida para o tratamento de transtornos do cns
PT2641596T (pt)	2018-07-31	Utilização de derivados de 1,3-difenilprop-2-en-1-ona para tratamento de doenças hepáticas
PL2049132T3 (pl)	2013-05-31	Nowe środki do leczenia zaburzeń związanych z osłabionym neuroprzekaźnictwem
BRPI0716981A2 (pt)	2013-10-15	Inibidores de cinase úteis para o tratamento de doenças proliferativas
PT1881823E (pt)	2015-03-02	Composições e métodos para o tratamento de transtornos oculares
BRPI0821660A2 (pt)	2015-06-16	Combinações de agentes terapêuticos para tratamento de câncer
BRPI0911577A8 (pt)	2018-03-06	derivados espiro-indol para o tratamento de doenças parasíticas.
BR112014013843A2 (pt)	2017-07-04	uso de dispositivos para o tratamento de doenças neurológicas
BRPI0819105A2 (pt)	2019-09-24	composição para o tratamento e prevenção de edema de pálpebra
DK2056842T3 (da)	2013-01-14	Modificeret galactosylceramid til behandling af cancerøse sygdomme
BRPI0919004A2 (pt)	2019-09-24	composto de multiheteroarila como inibidores de h-pgds e sua utilização para o tratamento de doenças mediadas por prostaglandina d2
ZA200907313B (en)	2011-03-30	Styrenyl derivative compounds for treating ophthalmic diseases and disorders
BRPI0917440A2 (pt)	2015-12-01	composições farmacêuticas oftálmicas para o tratamento de patologias neoangiogênicas do olho

Legal Events

Date	Code	Title	Description
2017-08-15	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2017-12-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]